Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group. [electronic resource]
Producer: 19851119Description: 379-92 p. digitalISSN:- 0263-6352
- Adult
- Blood Pressure
- Cardiovascular Diseases -- chemically induced
- Cerebrovascular Disorders -- chemically induced
- Clinical Trials as Topic
- Diuretics -- therapeutic use
- Double-Blind Method
- Drug Therapy, Combination
- Electrocardiography
- Female
- Humans
- Hypertension -- drug therapy
- Male
- Middle Aged
- Myocardial Infarction -- chemically induced
- Oxprenolol -- adverse effects
- Pulse
- Random Allocation
- Risk
- Smoking
- Sympatholytics -- therapeutic use
- Vasodilator Agents -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.